75 related articles for article (PubMed ID: 38474294)
1. Ubiquitination-mediated degradation of TRDMT1 regulates homologous recombination and therapeutic response.
Zhu X; Wang X; Yan W; Yang H; Xiang Y; Lv F; Shi Y; Li HY; Lan L
NAR Cancer; 2021 Mar; 3(1):zcab010. PubMed ID: 33778494
[TBL] [Abstract][Full Text] [Related]
2. Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.
Alkema NG; Wisman GB; van der Zee AG; van Vugt MA; de Jong S
Drug Resist Updat; 2016 Jan; 24():55-69. PubMed ID: 26830315
[TBL] [Abstract][Full Text] [Related]
3. Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System.
Wiedemeyer WR; Beach JA; Karlan BY
Front Oncol; 2014; 4():34. PubMed ID: 24624361
[TBL] [Abstract][Full Text] [Related]
4. Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background.
Chiappa M; Guffanti F; Grasselli C; Panini N; Corbelli A; Fiordaliso F; Damia G
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474294
[TBL] [Abstract][Full Text] [Related]
5. Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells.
Wang QE; Milum K; Han C; Huang YW; Wani G; Thomale J; Wani AA
Mol Cancer; 2011 Mar; 10():24. PubMed ID: 21385444
[TBL] [Abstract][Full Text] [Related]
6. MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.
Whicker ME; Lin ZP; Hanna R; Sartorelli AC; Ratner ES
BMC Cancer; 2016 Jul; 16():550. PubMed ID: 27465688
[TBL] [Abstract][Full Text] [Related]
7. Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant
Chiappa M; Guffanti F; Anselmi M; Lupi M; Panini N; Wiesmüller L; Damia G
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406579
[TBL] [Abstract][Full Text] [Related]
8. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin.
Jacquemont C; Simon JA; D'Andrea AD; Taniguchi T
Mol Cancer; 2012 Apr; 11():26. PubMed ID: 22537224
[TBL] [Abstract][Full Text] [Related]
9. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
10. Cancer statistics, 2024.
Siegel RL; Giaquinto AN; Jemal A
CA Cancer J Clin; 2024; 74(1):12-49. PubMed ID: 38230766
[TBL] [Abstract][Full Text] [Related]
11. ROS production by mitochondria: function or dysfunction?
Palma FR; Gantner BN; Sakiyama MJ; Kayzuka C; Shukla S; Lacchini R; Cunniff B; Bonini MG
Oncogene; 2024 Jan; 43(5):295-303. PubMed ID: 38081963
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA damage response pathways in cancer.
Groelly FJ; Fawkes M; Dagg RA; Blackford AN; Tarsounas M
Nat Rev Cancer; 2023 Feb; 23(2):78-94. PubMed ID: 36471053
[TBL] [Abstract][Full Text] [Related]
13. Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy.
Widmer CA; Klebic I; Domanitskaya N; Decollogny M; Howald D; Siffert M; Essers P; Nowicka Z; Stokar-Regenscheit N; van de Ven M; de Korte-Grimmerink R; Galván JA; Pritchard CEJ; Huijbers IJ; Fendler W; Vens C; Rottenberg S
Cancer Res Commun; 2022 Oct; 2(10):1266-1281. PubMed ID: 36467895
[TBL] [Abstract][Full Text] [Related]
14. CHAMP1 binds to REV7/FANCV and promotes homologous recombination repair.
Li F; Sarangi P; Iyer DR; Feng H; Moreau L; Nguyen H; Clairmont C; D'Andrea AD
Cell Rep; 2022 Aug; 40(9):111297. PubMed ID: 36044844
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of chemotherapy resistance in ovarian cancer.
Ortiz M; Wabel E; Mitchell K; Horibata S
Cancer Drug Resist; 2022; 5(2):304-316. PubMed ID: 35800369
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
